Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
It seems we are on the right track and more focused instead of being all over.
¿Qué es lo mejor de tu paquéte de compensación?
Health Care insurance & Vision Plan
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
Some of the individuals in the LT are still in toxic mode.
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
The team is willing to turn on the page and start with a fresh mindset; however, the SVP still has the old attitude. He does not motivate or inspire employees.
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
I like the new culture and the new LT members. They are sharp and have been in the industry for years. They will make a positive change to the company.
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
It makes me happy knowing that we can help patients in need. The KEAP program is a great example of what the company offers for people who cannot afford to pay for the drug.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×